Just as global concern about India’s abysmally low levels of testing in the face of the Covid-19 epidemic is mounting, along comes news in this country of paradoxes and contradictions that one of the most convenient hand-held devices to test whether a person is infected has been developed in India. MolBio Diagnostics, a Bengaluru-based biotech firm, has developed one that “can be used at the airport, in villages, or any other public place to give results within an hour,” according to a report in The Ken. Better still, it costs just Rs 1,500, less than a third of the government’s administered test. In Senegal, the Pasteur Institute has combined experience from developing yellow fever vaccines with instant pregnancy home test kits to prototype an even easier test for $1, but that is still three months away from being ready by which time this epidemic may have overwhelmed intensive care units in Europe, the US and Australia. Mol-Bio already uses a variation to test for tuberculosis in Andhra Pradesh. Xcyton can go beyond a positive/negative result on the SARS-CoV-2 virus and identify what kind of virus it is. In both cases, the companies – and India – would be helped by faster approvals of testing equipment by government agencies and a ramping up of the production of reagents required for the tests, which are currently imported.
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

